243 related articles for article (PubMed ID: 33132634)
21. Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.
Garside R; Pitt M; Somerville M; Stein K; Price A; Gilbert N
Health Technol Assess; 2006 Mar; 10(8):1-142, iii-iv. PubMed ID: 16545207
[TBL] [Abstract][Full Text] [Related]
22. [Barrett esophagus. Current situation of the risk and surveillance policy].
Robaszkiewicz M
Presse Med; 1994 Dec; 23(40):1846-8. PubMed ID: 7899314
[TBL] [Abstract][Full Text] [Related]
23. Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus.
Hamade N; Kamboj AK; Krishnamoorthi R; Singh S; Hassett LC; Katzka DA; Kahi CJ; Fatima H; Iyer PG
Aliment Pharmacol Ther; 2021 Sep; 54(5):546-559. PubMed ID: 34275161
[TBL] [Abstract][Full Text] [Related]
24. Barrett's mucosa, Barrett's dysplasia and Barrett's carcinoma: diagnostic endoscopy without biopsy-taking does not suffice.
Vieth M; Stolte M
Dis Esophagus; 2000; 13(1):23-7. PubMed ID: 11005327
[TBL] [Abstract][Full Text] [Related]
25. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
27. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
28. [Surveillance for Barrett's oesophagus: worthwhile?].
Kastelein F; Kuipers EJ
Ned Tijdschr Geneeskd; 2012; 156(49):A5497. PubMed ID: 23218039
[TBL] [Abstract][Full Text] [Related]
29. Barrett's oesophagus: the new endoscopic modalities have a future.
Deviere J
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i33-7. PubMed ID: 15711006
[TBL] [Abstract][Full Text] [Related]
30. Role of artificial intelligence in diagnosing Barrett's esophagus-related neoplasia.
Meinikheim M; Messmann H; Ebigbo A
Clin Endosc; 2023 Jan; 56(1):14-22. PubMed ID: 36646423
[TBL] [Abstract][Full Text] [Related]
31. Ablation of Barrett's oesophagus: towards improved outcomes for oesophageal cancer?
Mayne GC; Bright T; Hussey DJ; Watson DI
ANZ J Surg; 2012 Sep; 82(9):592-8. PubMed ID: 22901306
[TBL] [Abstract][Full Text] [Related]
32. Artificial intelligence-assisted esophageal cancer management: Now and future.
Zhang YH; Guo LJ; Yuan XL; Hu B
World J Gastroenterol; 2020 Sep; 26(35):5256-5271. PubMed ID: 32994686
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of Barrett's oesophagus.
Lim YC; Fitzgerald RC
Br Med Bull; 2013; 107():117-32. PubMed ID: 23926313
[TBL] [Abstract][Full Text] [Related]
34. Barrett's oesophagus.
Shaheen NJ; Richter JE
Lancet; 2009 Mar; 373(9666):850-61. PubMed ID: 19269522
[TBL] [Abstract][Full Text] [Related]
35. Diagnosing dysplasia in Barrett's oesophagus still requires Seattle protocol biopsy in the era of modern video endoscopy: results from a tertiary centre Barrett's dysplasia database.
Nachiappan A; Ragunath K; Card T; Kaye P
Scand J Gastroenterol; 2020 Jan; 55(1):9-13. PubMed ID: 31880176
[No Abstract] [Full Text] [Related]
36. Should patients with Barrett's oesophagus be kept under surveillance? The case against.
Barritt AS; Shaheen NJ
Best Pract Res Clin Gastroenterol; 2008; 22(4):741-50. PubMed ID: 18656827
[TBL] [Abstract][Full Text] [Related]
37. Endoscopic resection in neoplastic lesions of the oesophagus.
Pech O; May A; Rabenstein T; Gossner L; Ell C
Langenbecks Arch Surg; 2003 Dec; 388(6):421-4. PubMed ID: 14586661
[TBL] [Abstract][Full Text] [Related]
38. Artificial intelligence in upper GI endoscopy - current status, challenges and future promise.
Yu H; Singh R; Shin SH; Ho KY
J Gastroenterol Hepatol; 2021 Jan; 36(1):20-24. PubMed ID: 33448515
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system.
Curvers WL; Singh R; Song LM; Wolfsen HC; Ragunath K; Wang K; Wallace MB; Fockens P; Bergman JJ
Gut; 2008 Feb; 57(2):167-72. PubMed ID: 17965067
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic management of dysplasia and early oesophageal cancer.
Zeki SS; Bergman JJ; Dunn JM
Best Pract Res Clin Gastroenterol; 2018; 36-37():27-36. PubMed ID: 30551853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
